Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies
- PMID: 30818990
- PMCID: PMC6677250
- DOI: 10.1176/appi.ajp.2018.18070857
Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies
Abstract
Objective: Tourette's syndrome is polygenic and highly heritable. Genome-wide association study (GWAS) approaches are useful for interrogating the genetic architecture and determinants of Tourette's syndrome and other tic disorders. The authors conducted a GWAS meta-analysis and probed aggregated Tourette's syndrome polygenic risk to test whether Tourette's and related tic disorders have an underlying shared genetic etiology and whether Tourette's polygenic risk scores correlate with worst-ever tic severity and may represent a potential predictor of disease severity.
Methods: GWAS meta-analysis, gene-based association, and genetic enrichment analyses were conducted in 4,819 Tourette's syndrome case subjects and 9,488 control subjects. Replication of top loci was conducted in an independent population-based sample (706 case subjects, 6,068 control subjects). Relationships between Tourette's polygenic risk scores (PRSs), other tic disorders, ascertainment, and tic severity were examined.
Results: GWAS and gene-based analyses identified one genome-wide significant locus within FLT3 on chromosome 13, rs2504235, although this association was not replicated in the population-based sample. Genetic variants spanning evolutionarily conserved regions significantly explained 92.4% of Tourette's syndrome heritability. Tourette's-associated genes were significantly preferentially expressed in dorsolateral prefrontal cortex. Tourette's PRS significantly predicted both Tourette's syndrome and tic spectrum disorders status in the population-based sample. Tourette's PRS also significantly correlated with worst-ever tic severity and was higher in case subjects with a family history of tics than in simplex case subjects.
Conclusions: Modulation of gene expression through noncoding variants, particularly within cortico-striatal circuits, is implicated as a fundamental mechanism in Tourette's syndrome pathogenesis. At a genetic level, tic disorders represent a continuous spectrum of disease, supporting the unification of Tourette's syndrome and other tic disorders in future diagnostic schemata. Tourette's PRSs derived from sufficiently large samples may be useful in the future for predicting conversion of transient tics to chronic tic disorders, as well as tic persistence and lifetime tic severity.
Keywords: Child Psychiatry; Genetics; Genome-Wide Association Study; Tic Disorders; Tourette Syndrome.
Figures



References
-
- Robertson MM, Eapen V, Singer HS, Martino D, Scharf JM, Paschou P, et al. Gilles de la Tourette syndrome. Nature reviews Disease primers. 2017;3:16097. - PubMed
-
- Mataix-Cols D, Isomura K, Perez-Vigil A, Chang Z, Ruck C, Larsson KJ, et al. Familial Risks of Tourette Syndrome and Chronic Tic Disorders. A Population-Based Cohort Study. JAMA Psychiatry. 2015;72(8):787–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS102371/NS/NINDS NIH HHS/United States
- U01 HG004438/HG/NHGRI NIH HHS/United States
- R01 NS096008/NS/NINDS NIH HHS/United States
- P01 AG021654/AG/NIA NIH HHS/United States
- P01 CA089392/CA/NCI NIH HHS/United States
- R01 NS016648/NS/NINDS NIH HHS/United States
- R01 MH092520/MH/NIMH NIH HHS/United States
- R01 NS040024/NS/NINDS NIH HHS/United States
- U10 AA008401/AA/NIAAA NIH HHS/United States
- R01 NR014852/NR/NINR NIH HHS/United States
- R01 AG042188/AG/NIA NIH HHS/United States
- R01 MH092292/MH/NIMH NIH HHS/United States
- R01 MH092516/MH/NIMH NIH HHS/United States
- U01 HG004446/HG/NHGRI NIH HHS/United States
- R01 MH092513/MH/NIMH NIH HHS/United States
- K23 MH085057/MH/NIMH NIH HHS/United States
- R01 MH104964/MH/NIMH NIH HHS/United States
- R01 MH115993/MH/NIMH NIH HHS/United States
- R01 NS105746/NS/NINDS NIH HHS/United States
- R01 MH092291/MH/NIMH NIH HHS/United States
- R25 MH077823/MH/NIMH NIH HHS/United States
- U01 NS040024/NS/NINDS NIH HHS/United States
- R01 MH115958/MH/NIMH NIH HHS/United States
- R01 MH096767/MH/NIMH NIH HHS/United States
- P30 NS062691/NS/NINDS NIH HHS/United States
- RA/ARRA NIH HHS/United States
- R01 MH092289/MH/NIMH NIH HHS/United States
- HHSN268200782096C/HG/NHGRI NIH HHS/United States
- R01 MH092290/MH/NIMH NIH HHS/United States
- U01 HG004422/HG/NHGRI NIH HHS/United States
- K02 NS085048/NS/NINDS NIH HHS/United States
- U01 MH109536/MH/NIMH NIH HHS/United States
- R01 DA013423/DA/NIDA NIH HHS/United States
- R01 MH115961/MH/NIMH NIH HHS/United States
- R01 MH085548/MH/NIMH NIH HHS/United States
- U24 MH068457/MH/NIMH NIH HHS/United States
- R01 MH123451/MH/NIMH NIH HHS/United States
- P30 AG038072/AG/NIA NIH HHS/United States
- R01 MH115963/MH/NIMH NIH HHS/United States
- R01 MH092293/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous